Connect your AI

Cardinal Health CAH Pharmaceutical and Specialty Solutions — Percent of Gross Trade Receivables

Similar metrics at other companies

VCYTBiopharmaceutical and other revenue — Accounts receivable

$1.1M-78.4%

ACIPharmacy — Receivables, net

$519.8M+12.0%

LKQSpecialty — Receivables, net of allowance for credit losses

$200M+13.6%

MNKDProduct — Percentage Of Accounts Receivable From Major Customers

54%-32.0pp

DGXDS businesses — Percentage of net accounts receivable

0.5%0.0pp

AUPHSpecialty pharmacy B — Concentration risk percentage

9.5%-0.3pp

Other financials

Income statement

Revenue$60.9B+11.0%

Gross profit$2.5B+17.7%

Operating income$509.0M-30.3%

Net income$399.0M-21.1%

EPS (diluted)$1.69-19.5%

Balance sheet

Cash & equivalents$3.9B+18.4%

Total debt$8.9B+16.1%

Total equity-$2.8B+3.9%

Total assets$56.7B+13.7%

Cash flow

Operating cash flow$1.8B-37.6%

CapEx$146.0M+15.9%

Free cash flow$1.7B-40.0%

Valuation

Market cap$54.98B+41.0%

Enterprise value$59.96B+38.3%

P/E35.4×+10.3×

P/S0.2×0.0×

Profitability

Gross margin3.8%+0.2pp

Operating margin0.9%-0.1pp

Net margin0.6%-0.1pp

FCF margin1.7%+0.6pp

Returns & leverage

Return on equity37.4%—

Debt / equity4.1×—

Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept cah:GrossTradeReceivablesMajorCustomerPercentage.

The official record: Cardinal Health’s 10-K, filed August 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's pharmaceutical and specialty solutions — percent of gross trade receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Cardinal Health's pharmaceutical and specialty solutions — percent of gross trade receivables?: Cardinal Health (CAH) reported pharmaceutical and specialty solutions — percent of gross trade receivables of 26% in Q2 2025.
What does pharmaceutical and specialty solutions — percent of gross trade receivables mean?: This metric measures the portion of total gross trade receivables attributed to specific customer segments or entities within the pharmaceutical distribution business. It helps assess credit risk exposure and the effectiveness of collection cycles for the segment's primary client base.